PVG Asset Management’s MAIA Biotechnology MAIA Stock Holding History

PVG Asset Management’s Portfolio MAIA Stock Details MAIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$40.3K	Hold	34,135	–	–	0.03%	125
2026 Q2	$49.2K	Hold	34,135	–	–	0.03%	130
2026 Q1	$46.4K	Buy	+34,135	New	+$62.9K	0.03%	123

Other funds holding MAIA

Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Centerpoint Advisory Group Overland Park, Kansas $161M AUM 19.32% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

PVG Asset Management's MAIA Position: Q3 2026 in Review

PVG Asset Management held its MAIA Biotechnology (MAIA) position steady in Q3 2026 at 34,135 shares worth $40.3K. The position accounts for 0.03% of the portfolio, ranked #125.

PVG Asset Management first reported a position in MAIA in Q1 2026 and has held it in 3 quarters since. The position peaked at $49.2K in Q2 2026. 7 funds tracked by Wall St. Rank hold MAIA as of Q3 2026.

PVG Asset Management held 34,135 shares of MAIA Biotechnology worth $40.3K as of Q3 2026.
PVG Asset Management left its MAIA Biotechnology share count unchanged in Q3 2026.
MAIA Biotechnology made up 0.03% of PVG Asset Management's portfolio in Q3 2026, its #125 holding.
PVG Asset Management first reported a position in MAIA Biotechnology in Q1 2026 and has held it in 3 quarters since.
PVG Asset Management's MAIA Biotechnology position peaked at $49.2K in Q2 2026.
7 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q3 2026.

Based on PVG Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.